help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trocino, R. A.
Right arrow Articles by Nagataki, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trocino, R. A.
Right arrow Articles by Nagataki, S.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Diabetes and Pregnancy
*High Risk Pregnancy

Endocrinology, Vol 134, 869-878, Copyright © 1994 by Endocrine Society


ARTICLES

Cellular-tissue localization and regulation of the GLUT-1 protein in both the embryo and the visceral yolk sac from normal and experimental diabetic rats during the early postimplantation period

RA Trocino, S Akazawa, H Takino, Y Takao, K Matsumoto, Y Maeda, S Okuno and S Nagataki
First Department of Internal Medicine, Nagasaki University School of Medicine, Japan.

We investigated the tissue-specific developmental expression and localization of GLUT-1 protein in the rat embryo and visceral yolk sac (VYS) during the organogenic periods of normal rats. The expression of GLUT-1 protein was then compared to that of experimental diabetic rats to test whether the diabetic state would affect the regulation of the glucose transporter during the early postimplantation periods (9.5-14.5 days), as we have previously demonstrated that GLUT-1 protein in embryo and VYS was down-regulated in culture with hyperglycemic medium. In the embryo, GLUT-1 protein was highly expressed during the early stages of organogenesis (between 9.5-12.5 days) and declined thereafter, whereas in the VYS, its strong expression was observed at the later stages (from 12.5-14.5 days). Immunohistochemical localization of the GLUT-1 protein in the embryo during the main periods of neurulation (9.5-11.5 days) showed that GLUT-1 immunoreactivity was principally observed in the neuroepithelial cells of the neural tube and also noted in the primitive heart, primitive gut, otic, and optic vesicles. At 12.5 days, GLUT-1 protein started to be expressed in the microvessels at the cranial portions of the neural tube, although its expression in the neuroepithelial cells still remained at the caudal (tail) portions of the neural tube. In the later stages (13.5-14.5 days) after completion of neural tube formation, GLUT-1 protein immunoreactivity substantially decreased in the neuroepithelial cells and was found mainly in the microvessels of the brain vesicles and spinal cord, whereas it continued to be expressed in the heart and eyes. In the VYS, its immunoreactivity was noticeably confined to the endodermal layer, which started as a simple layer and developed wave-like folds in the later stages. The levels of GLUT-1 protein in embryo and VYS from diabetic rats, determined by Western blot analysis, were not down-regulated compared to those in control rats at the different gestational days. Likewise, comparison of GLUT-1 protein immunoreactivity of various tissues in embryo and VYS, focusing on the neural tube, also revealed no significant differences between the two groups. We demonstrated that GLUT-1 protein is abundantly expressed in embryonic tissues and VYS during the early periods of organogenesis. The lack of down-regulation and the continuous abundant expression of the GLUT-1 protein despite the diabetic state in embryo and VYS during the early postimplantation periods may increase delivery of glucose from the VYS into various differentiating embryonic cells, leading to diabetes-induced congenital malformations.


This article has been cited by other articles:


Home page
Reproductive SciencesHome page
C. M. Davidson, H. Northrup, T. M. King, J. M. Fletcher, I. Townsend, G. H. Tyerman, and Kit Sing Au
Genes in Glucose Metabolism and Association With Spina Bifida
Reproductive Sciences, January 1, 2008; 15(1): 51 - 58.
[Abstract] [PDF]


Home page
Reproductive SciencesHome page
Z. Zhao and E. A. Reece
Experimental Mechanisms of Diabetic Embryopathy and Strategies for Developing Therapeutic Interventions
Reproductive Sciences, December 1, 2005; 12(8): 549 - 557.
[Abstract] [PDF]


Home page
Biol. Reprod.Home page
E. Turkay Korgun, R. Demir, A. Hammer, G. Dohr, G. Desoye, G. Skofitsch, and T. Hahn
Glucose Transporter Expression in Rat Embryo and Uterus During Decidualization, Implantation, and Early Postimplantation
Biol Reprod, November 1, 2001; 65(5): 1364 - 1370.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. C. E. Peeters, J. L.M.C. Geelen, J. W. M. Hekking, N. Chavannes,, J. P. M. Geraedts, and H. W. M. van Straaten
Reduced Glucose Consumption in the Curly Tail Mouse Does Not Initiate the Pathogenesis Leading to Spinal Neural Tube Defects
J. Nutr., October 1, 1998; 128(10): 1819 - 1828.
[Abstract] [Full Text]


Home page
J. Cell Biol.Home page
H.-D. Gabriel, D. Jung, C. Butzler, A. Temme, O. Traub, E. Winterhager, and K. Willecke
Transplacental Uptake of Glucose Is Decreased in Embryonic Lethal Connexin26-deficient Mice
J. Cell Biol., March 23, 1998; 140(6): 1453 - 1461.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society